Title: Laboratory tests are ordered by the clinician for one of four reasons
1Laboratory tests are ordered by the clinician
for one of four reasons
- Screening - used in the general population
- - to find silent
disease - Case finding - to find disease
- in specific
clinical populations at risk - Diagnostic testing - as rule-in / rule-out tool
to -
- convince patients of their benign condition, - -
- to justify the clinicians procedere, - -
- for medico-legal safeguarding - Monitoring used to
- - monitor the progress of disease,
- -
response to therapy, - - concentration of medication.
2Sample Collecting body
substances blood, urine, faeces, sweat
etc. collected in
URINE/STOOL/BLOOD - CONTAINERS
Phlebotomists Equipment VACUTAINER TUBES
-
o EDTA (Lavender) o SST
(Gold/ Serum) o SST
(Speckled/Serum) o Citrate/Clotting (Lt
Blue) o Fluoride Oxalate/Glucose (Grey)
o Lithium Heparin (Green) o No
Additive (Red) o Sod. Heparin
(Dark Blue)
VACUTAINER NEEDLES o 21 Gauge (Green)
o 21 Butterfly (Green) o 22 Gauge
(Black) o 23 Gauge Butterfly (Blue) o
VACUTAINER BARREL
3How can one define a Healthy Population ?
- Health or Disease diagnosis
- relies on findings of
- true-negatives or true-positives
- hampered by
-
false-negatives or false positives - Is it possible to find a truly normal
individual ? or a healthy population whose
physiology is truly perfect ? - Without an ideal population any stated
reference range will be falsly broad ( the 95
water-shed) - Optimal metabolic ranges may be quite narrow for
many biochemical parameters
4Laboratory / Path-Lab. Tests
- Routine Health Service tests
- Blood Chemistry
- Blood Film Examination
- Urine-analysis
- Microbiology
- Special Health Service tests
- Cytology
- Microscopy
- Aspirated Material
- - Exsudates
- - Transudates
5Blood Chemistry
- Electrolytes
- Lipid-Profile
- Diabetes Check, RBS, GTT, HBA1c
- Renal Profile
- Hormone Assays Progesteron Estradiol,
Testosterone, DHEA, ACTH, Catecholamines - Serum Protein Electrophoresis
- Inflammation Markers ESR, CRP
- Tumor Markers
- PSA, AFP, CEA, ß-HCG
- CA153. CA27-29, CA19-9, CA 125, HER-2-neu,
- Miscellanious LDH, AP
6Serum Sodium (Na)- major extra-cellular cation
- regulates blood and volume by its osmotic
activity in the plasma (Osmolality) and in the
lymphatic tissues - excreted by the kidneys, sweating
- increased Cushings Syndrome, drug-effects
- decreased Addisons Disease, renal failure,
metabolic acidosis, malignancies, drugs
7Serum Potassium (K)- major intra-cellular cation
- - distal tubular secretion dependent on
mineralcorticoids, -
acid-base balance - drugs
- major influence on muscle activity
- if unbalanced
- diagnosis whether Hypo- or Hyper-kalaemia
required - diagnosis whether Hypo- or Hyper-Adrenalism
present - risk of metabolic / respiratory alkalosis or
acidosis present
8Plasma Creatinineby-product from
Creatine-metabolism
- single most useful measurement of renal
function - normally varies little throughout the day
- best monitoring tool for renal secretory
function glomerular filtration rate GFR
9Urea NH2CONH2
- - produced by protein consumption and the
formation of ammonia - raised levels (Uraemia/ Azotaemia)
- - sign of chronic renal failure,
- - can have pre-renal, renal and post-renal
cause - - can lead to Uraemic Syndrome, nausea,
confusion . .
10Uric Acid
- - end product of purine metabolism
- ? (Hper-uricemia) - predictive of gout ,
- ? poly-cystic kidney disease, anemias
- ? hypothyroidism
- ? diuretics, salicylate
11Calcium (Ca2)
- defines clinical diagnosis whether Hypo- or
Hyper-calcaemia - clinically linked with 1-ary
Hyper-Parathyroidism, - effects of drugs, radiation,
malignancy, - clinically linked with Hypo-Parathyroidism
- associated with other endocrine disorders,
- - symptomatically cramps, spasms, tetany. nail
skin disorders -
12Diabetic Monitoring
- Normal Serum Glucose Concentration
75mg-110mg/dl - 4.2 - 6.4 (mmol/l in SI units
- Glucose Tolerance Test (GTT) lt 7.8 (8.9
mmol/l ) - (2 hr post-glucose loading analysis)
- Glycosylated Hemoglobin ( HbA1c) n.r. (
3.8 6.4) - dependent on circulating erythrocyte (120
days) - Further Glycaemic Testing becomes
- indicated after symptom development -
excessive thirst, glycosuria, skin irritation - (if Random BS gt 11 mmol/l ? Diabetes )
-
- fasting glucose gt 7
mmol/l -
- plasma glucose 2 hrs
after GTT-loading gt 11.1
13Serum-Lipids
- Cholesterol insoluble in water carrier
proteins Lipoproteins - desirable borderline high .
- Total Cholesterol lt 200 200 240
gt 240 mg/dl - 5.2 6.1
S.I. - Triglycerides lt 150 150 200
gt 200 - 1.7 2.25
- LDL- Cholesterol lt 130 130 160 gt
160 - 2.6
4.1 - LDL- Cholesterol gt 60 if less than 39
- 1.5
1.
14Liver Function Tests
- Serum Transaminases
- Serum Aspartate Transaminase (AST or SGOT)
- Serum Alamine Aminotransferase (ALT or SGPT)
- Serum Alkaline Phosphatase (AP)
- Serum Gamma Glutamyl Transpeptidase (GGT)
- Serum Bilirubin
- Serum Albumin
15Bilirubin waste-product of the erythrocyte
degradation cycle
? Serum ( free or un-conjugated B. - as
bilirubin-albumin complex ) (
conjugated in liver - as bilirubin
glucoronide )
- ? conjugated - hepatobiliary disease
- - obstructive post-hepatic
jaundice - ? un-conjugated - Gilberts Syndrome,
neonatal jaundice - - haemolysis, pre-hepatic jaundice
? Urine (uro-bilinogen) hemolytic anemia,
toxic hepatitis, mononucleosis
16Clinical Hematology examines ( sample bottle EDTA)
- BLOOD CELL DEVELOPMENT of
- Red Blood Cells (RBCs, Erythrocytes) White Blood
Cells (WCs, Leukocytes) - BLOOD CELL COUNTS
- Units Reported By Automated Counting (RBCs),
(WC), Platelets - Complete blood count CBC HEMOGLOBIN -
Variants - HEMATOCRIT (PACKED CELL VOLUME)
- REDCELL- Count - with morphology
- - MCV, MCH, MCHC,
- PLATELETS
- WHITE-CELL- Count with morphology
- WHITE-CELL- Count with DIFFERENTIAL
Count - Neutrophils
- Eosinophils
- Basophils
- onocytes
- Lymphocytes
- EXAMINATION OF THE PERIPHERAL BLOOD FILM
- Microscopic Examination of the Blood Film Normal
Leukocyte Morphology
17Red-Cell (Erythrocyte) Population PERIPHERAL
BLOOD FILM differentiation by Color, Shape
-
- -normochromic
- - hypochromic
- - hyperchromic
Macro-cytosis ? Megaloblastic
Anemia Micro-cytosis ? Iron-deficincy-An. Anis
o-cytosis Poikolo-cytosis Presence of
Sickle-cells Target-cells
Helmet-cells Spherocytes
Hemoglobin Variants S, C, D, E
Hemoglobin-Derivatives ? Microcirculation
(Met-, Oxy-, Carboxy-, Cyanomet- H. )
18Smallest integral life forms observed under
Darkfield Microscopy seen as "tiny white dots"
so called Protits they change according
Pleomorphism or the Cyclogenia of Microbes first
into viral forms which can change into
bacterial forms followed by spores
and fungi.
19White-Cell (Leukocyte) -Population
- PERIPHERAL BLOOD FILM
- if increased
- Myeloid Series (?) ?
(leucocytosis) - Neutrophils ? (neutrophilia )
- Eosinophils ? (eosinophilia )
- Basophils
- Monocytes
- Lymphocytes (?) small, large, reactive ?
(lymphocytosis) - DEFICIENCIES
- Leukopenia, Neutropenia,
Lymphocytopenia etc
20Fatigue Signs I Symptoms I Findings
- Ongoing fatigue
- - reduced daily activity
- - very limited exercise tolerance
- Muscle pain
- - worse after exercise
- Migrating polyarthralgia
- Recurrent headaches
- Depression
- Cognitive disturbances
- Low blood pressure / Postural hypotension
21- Commonly reported Symptoms Findingsfrom a
large number of dys-functional individuals - Fatigued easily out of puff
- Muscle weakness, muscle pain, - worse after
exercise - Migrating polyarthralgia, joints ache, - feel
stiff - Sleep disturbance -Insomnia - Hypersomnia
- Low grade feverishness, sweating disorder,
- Chronic sore throat, - swollen lymph nodes
- Recurrent headaches, unexplained depression
- Cognitive disturbances, - snowflakes, buzzing
noises, - crawling
sensation, brain fag - Low morning blood pressure, - postural
hypotension - Reduced daily activity, - very limited
exercise tolerance
22Disease Labeling or Health Monitoring ?
- Functional Lab-Assessment
- Why?
- Complex InterRelationships
- Connectedness of Symptoms
- quantifies Function
- Traditional Lab-testing
- What ?
- identify single cause
- Separation of Symptoms
- quantifies Pathology
23. . is there a shift in the spectrum of diseases
that we see and experience ?
- . . need for new biochemical
- ( or other ! ) markers ?
- - not only to diagnose disease
- - sensitive to monitor metabolism more
dynamically - - treatment progress
- T1 T2 responses
- Neurotransmitters, Cytokines, Trace-elements
- Antioxidfant-Activity, DNA-adducts
- Endocrine Disruptors , Free
- pleo-morphic shift of pathogens,
life-blood-analysis - Apoptosis
24Microbial Pathogens
- VIRUSES -100 nanometers,
- multiply through host DNA
- BACTERIA - at least 10 times larger than
viruses, - 1 mcmr (1 millionth of a meter) -
reproduce independently - SINGLE-CELL - at least 100 times larger,
0.1 millimeter long - PARASITES
- MULTI CELLULAR - can be seen with the naked
eye - PARASITES
- Pleomorphism theory of dynamic
changes and - transmutations between pathogens